INTRODUCCIÓN: REVISIÓN CRITICA DEL PROBLEMA

CAPÍTULO VIII
298. Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk
for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol.
2005 Dec 7;105(3):315-8.
299. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J, Brancati
FL. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl
J Med. 2010 Mar 4;362(9):800-11.
300. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe
D, Oates PJ, Hammes HP, Giardino I, Brownlee M.Normalizing mitochondrial superoxide
production blocks three pathways of hyperglycaemic damage. Nature. 2000 Apr
13;404(6779):787-90.
301. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001
Dec 13;414(6865):813-20.
302. Fiordaliso F, Cuccovillo I, Bianchi R, Bai A, Doni M, Salio M, De Angelis N, Ghezzi P, Latini
R, Masson S.Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat
model of streptozotocin-induced diabetes. Life Sci. 2006 Jun 6;79(2):121-9.
303. Kato T, Yamashita T, Sekiguchi A, Tsuneda T, Sagara K, Takamura M, Kaneko S, Aizawa
T, Fu LT. AGEs–RAGE system mediates atrial structural remodeling in the diabetic rat. J
Cardiovasc Electrophysiol. 2008 Apr;19(4):415-20.
304. Van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K,
Ijsselmuiden AJ, Schalkwijk CG, Bronzwaer JG, Diamant M, Borbély A, van der Velden J,
Stienen GJ, Laarman GJ, Niessen HW, Paulus WJ.Diastolic stiffness of the failing
diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte
resting tension. Circulation. 2008 Jan 1;117(1):43-51.
305. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A,
Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern
D, Schmidt AM. RAGE mediates a novel proinflammatory axis: a central cell surface
receptor for S100/calgranulin polypeptides. Cell. 1999 Jun 25;97(7):889-901.
306. Boos CJ, Lip GY. Inflammation and atrial fibrillation: cause or effect? Heart. 2008
Feb;94(2):133-4.
307. Wong RK, Pettit AI, Quinn PA, Jennings SC, Davies JE, Ng LL. Advanced glycation end
products stimulate an enhanced neutrophil respiratory burst mediated through the
activation of cytosolic phospholipase A2 and generation of arachidonic acid. Circulation.
2003 Oct 14;108(15):1858-64.
308. Mukherjee R, Herron AR, Lowry AS, Stroud RE, Stroud MR, Wharton JM, Ikonomidis JS,
Crumbley AJ 3rd, Spinale FG, Gold MR. Selective induction of matrix metalloproteinases
and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients
with atrial fibrillation. Am J Cardiol. 2006 Feb 15;97(4):532-7.
309. Nakano Y, Niida S, Dote K, Takenaka S, Hirao H, Miura F, Ishida M, Shingu T, Sueda T,
Yoshizumi M, Chayama K. Matrix metalloproteinase-9 contributes to human atrial
remodeling during atrial fibrillation. J Am Coll Cardiol. 2004 Mar 3;43(5):818-25.
310. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007 Sep;93(9):1137-46.
311. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll
Cardiol. 2008 Nov 4;52(19):1527-39.
312. Shishehbor MH, Oliveira LP, Lauer MS, Sprecher DL, Wolski K, Cho L, Hoogwerf BJ, Hazen
SL. Emerging cardiovascular risk factors that account for a significant portion of
attributable mortality risk in chronic kidney disease. Am J Cardiol. 2008 Jun
15;101(12):1741-6.
313. Grigorian Shamagian L, Varela Román A, Pedreira Pérez M, Gómez Otero I, Virgós Lamela
A, González-Juanatey JR. Renal failure is an independent predictor of mortality in
hospitalized heart failure patients and is associated with a worse cardiovascular risk
profile. Rev Esp Cardiol. 2006 Feb;59(2):99-108.
242